Back to Journals » Vascular Health and Risk Management » Volume 8

The predictive power of depression screening procedures for veterans with coronary artery disease

Authors Shankman SA, Nadelson J, McGowan SK, Sovari AA, Vidovich MI

Received 23 December 2011

Accepted for publication 8 February 2012

Published 17 April 2012 Volume 2012:8 Pages 233—238

DOI https://doi.org/10.2147/VHRM.S29424

Review by Single-blind

Peer reviewer comments 3

Stewart A Shankman1*, Jeffrey Nadelson2*, Sarah Kate McGowan1, Ali A Sovari2, Mladen I Vidovich2
1
Department of Psychiatry and Psychology, University of Illinois, 2Department of Cardiology, Jesse Brown VA Medical Center, Chicago, IL, USA

*These authors contributed equally to this work

Abstract: Depression leads to a worse outcome for patients with coronary artery disease (CAD). Thus, accurately identifying depression in CAD patients is imperative. In many veterans affairs (VA) hospitals, patients are screened for depression once a year using the patient health questionnaire (PHQ-9). Although the PHQ-9 is generally considered a specific and sensitive measure of depression, there is reason to believe that these screening procedures may miss a large number of cases of depression within CAD patients and cardiology patients more generally. The goal of this study was to provide data as to the predictive power of this depression screening procedure by (a) comparing the prevalence rate of depression identified by the PHQ-9 to known prevalence rates and (b) examining whether patients identified as “depressed” also had conditions that consistently co-occur with depression (eg, post-traumatic stress disorder [PTSD], other medical issues). Participants were 813 consecutive patients who received an angiogram in the cardiac catheterization laboratory at a large VA Medical Center. Prevalence of depression was 6.9% in the overall sample and less than 6% when the sample was restricted to CAD patients with significant stenosis. Depression was significantly associated with PTSD, smoking, and alcohol problems. However, depression was not associated with other medical problems such as diabetes, renal failure, peripheral vascular disease, or anemia. In conclusion, the low prevalence rate of depression and lack of associations with comorbid medical problems may suggest that the VA’s depression screening procedures have low sensitivity for identifying depression in CAD patients. It is recommended that clinicians treating CAD regularly screen for depression and do not rely on archival depression screens.

Keywords: depression screening, coronary artery disease, PHQ-9, veterans

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]

 

Readers of this article also read:

Progression of carotid-artery disease in type 2 diabetic patients: a cohort prospective study

Bosevski M, Stojanovska L

Vascular Health and Risk Management 2015, 11:549-553

Published Date: 16 October 2015

Blood pressure control to prevent decline in cognition after stroke

Ihle-Hansen H, Thommessen B, Fagerland MW, Øksengård AR, Wyller TB, Engedal K, Fure B

Vascular Health and Risk Management 2015, 11:311-316

Published Date: 9 June 2015

Alogliptin benzoate for management of type 2 diabetes

Saisho Y

Vascular Health and Risk Management 2015, 11:229-243

Published Date: 10 April 2015

Breast cancer therapy and cardiovascular risk: focus on trastuzumab

Sandoo A, Kitas GD, Carmichael AR

Vascular Health and Risk Management 2015, 11:223-228

Published Date: 7 April 2015

Platelet function tests: a comparative review

Paniccia R, Priora R, Alessandrello Liotta A, Abbate R

Vascular Health and Risk Management 2015, 11:133-148

Published Date: 18 February 2015

Mipomersen and other therapies for the treatment of severe familial hypercholesterolemia

Bell DA, Hooper AJ, Watts GF, Burnett JR

Vascular Health and Risk Management 2012, 8:651-659

Published Date: 28 November 2012